To stop or not to stop: what should we be doing with biologic DMARDs when patients undergo orthopaedic surgery?

van Duren, BH, Wignall, A, Rangan, A et al. (3 more authors) (2021) To stop or not to stop: what should we be doing with biologic DMARDs when patients undergo orthopaedic surgery? Rheumatology Advances in Practice, 5 (3). rkab057. ISSN 2514-1775

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © The Author(s) 2021. Published by Oxford University Press on behalf of the British Society for Rheumatology. This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Dates:
  • Accepted: 2 August 2021
  • Published (online): 27 September 2021
  • Published: 27 September 2021
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Institute of Rheumatology & Musculoskeletal Medicine (LIRMM) (Leeds) > Experimental Musculoskeletal Medicine (Leeds)
The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Institute of Rheumatology & Musculoskeletal Medicine (LIRMM) (Leeds) > Orthopaedics (Leeds)
Depositing User: Symplectic Publications
Date Deposited: 04 Aug 2021 15:19
Last Modified: 06 Dec 2021 11:30
Status: Published
Publisher: Oxford University Press
Identification Number: https://doi.org/10.1093/rap/rkab057

Download

Export

Statistics